Navigation Links
Media Messages Can Serve To Reduce Smoking Indoors

Passive smoking which usually takes place at home can be reduced by the health warning ‘Smoking is injurious to health’. An American Journal of Health Behavior// study has revealed this, which stated that smoking at home may be restricted as people realize the harmful effects of second hand smoke.

Secondhand smoke exposure has been linked to lung cancer and heart disease in adults and severe respiratory infections and asthma, particularly in infants and young children. Anti-secondhand smoke media account for 10% of people’s negative attitudes about secondhand smoke, but these negative attitudes explain nearly 60% of home smoking restrictions.

“Media works through changing people’s attitudes to get them to change home smoking rules,” said lead researcher W. Douglas Evans. People may have to process the information they get from the media through family discussions or through one person in a household taking a strong position on secondhand smoke before the change in attitude becomes a change in home restrictions, Evans suggested.

The researchers measured the link between anti-secondhand smoke messages and home restrictions through a survey of 2,348 adults conducted by the American Legacy Foundation, a nonprofit anti-smoking foundation. About 23% of those surveyed were current smokers.

Researchers asked the survey participants whether they had seen news stories or ads about “the dangers of kids being around cigarette smoke” and “efforts to ban smoking in public places,” among other questions. They also asked the participants to agree or disagree with statements such as, “It is harmful to a person’s health if they live in a house where a smoker smokes tobacco indoors” or, “Inhaling someone else’s cigarette smoke can cause lung cancer in nonsmokers.”

Only 11% of those surveyed lived in a house with no smoking restrictions, while 65% of those surveyed had complete smoking bans within their homes.


'"/>




Page: 1 2

Related medicine news :

1. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
2. Scientist Calls Upon Media To Retract His Work
3. Media Plays Crucial Role In Flu Vaccinations
4. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
5. Medias Plays Vital Role In Sexual Behavior Of Teenagers
6. Long Term Mediation Not Advisable To Treat Hot Flashes
7. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
8. OBC Stir Media Creation: Ramadoss
9. Anti-quota Stir is a Creation of the Media: Ramadoss
10. Junk Food Advertisements To Be Restricted In All Forms of Media
11. Media Charged With Sensationalism
Post Your Comments:
(Date:10/10/2008)...op some form of disease by 20 years after operatio...hDay News) -- Liver transplant patients have a hig...n, say researchers in Finland. , In a new stud...antation , researchers investigated the cancer ris...ts from Helsinki University Central Hospital. The ...
(Date:10/10/2008)...t. 10 /PRNewswire-FirstCall/ -- Synvista,Therapeut...inted William,(Bill) Federici, 49, to its Board of... Mr. Federici joined West Pharmaceutical Services ...ugust of 2003. Under his financial leadership,Wes...n $1.0 billion from,$300 million. He has more than...
(Date:10/10/2008)...ct. 10 /PRNewswire/ -- More than 600 new Wisconsin...al election. This is the,result of Aurora Health C...Oct. 9, at all of the health care system,s 13 hosp...ple signed up to vote at the drives., Aurora empl...onsin,Government Accountability Board to serve as ...
(Date:10/10/2008)...t. 10 /PRNewswire-FirstCall/ -- Hologic, Inc.,(Nas...d supplier of premium,diagnostics, medical imaging...g the healthcare needs of women, today announced p... operating results on Tuesday, November 11,2008 a..., management will,host a conference call on Tuesda...
Breaking Medicine News(10 mins):Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2
...medical practitioner of Indian origin in the US ha...ith unauthorized drugs and insecticides // . He wa...US$ 100,000 by an Atlanta court. His assistant Dan...State Medical Board contends that his continued pr...
...importance of thiamine (vitamin B1) states that a ...plication after a surgery to treat obesity//. Thi...scientific journal of the American Academy of Neur...at if untreated, vitamin B1 deficiency can lead to...
...d in public places may save lives of cardiac patie...k by delivering a controlled// electric shock thro...l heartbeat after a cardiac arrest. Modern defibri...singly quick and easy for the layman to use, which...
...and Finch showed the effect of childhood infection...developing cardiovascular diseases // . They coll...pean countries- Sweden, France, England and Switze...th individuals born in 1899. After that in 1900 mo...
Other Medicine News:
(Date:10/9/2008)...ts Expected in November 2008, BOTHELL, Wash., Oct...Amex: DDD ) announced today the completion of pat...ree pivotal trials to evaluate the safety and,effi...e (ER) ibuprofen for,the over-the-counter (OTC) ma...ts from this pivotal trial in November 2008. Ibupr...
(Date:10/8/2008)...Inform Treatments for Spinal Cord, Other Nerve,Inj...ire/ -- A protein that enables,nerve cells to comm...lling,the developing nervous system. Research into...m among nerve cells may provide a basis for eventu...their nervous system,including spinal cord injury...
(Date:10/8/2008)...Potency of Poly-ICR as Vaccine Adjuvant, SAN DIEG...maceuticals,Corporation (TSX: NVN) today presented...proprietary Toll-like Receptor 3 agonist, Poly IC-...gress 2008 in Lyon, France.,Study results demonstr...eting the Toll-like Receptor 3 (TLR3) pathway. Dat...
(Date:10/7/2008)...y of new device for detecting polyps that can be ...RLANDO, Fla., Oct. 7 /- At the Americ...eeting in Orlando (ACG 2008), renowned,gastroenter...a,multi-institutional clinical study that evaluate...a new device that is designed to improve the abili...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference 7403 1Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference 7403 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 1Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 2Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World All Comers Clinical Study 2916 3Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 25916 1Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 25916 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 1TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 3
...inocycline Showed Substantial,Reduction of Disease...ing Multiple Sclerosis , Combination Treatment Wit... Well Tolerated , KANSAS CITY, Mo, May 4, 2007 - N...ed that a combination of Copaxone,(glatiramer acet...cycline reduced T1 Gadolinium (Gd)-enhancing lesio...
...E)--May 4, 2007 - New data from a,randomized, doub...NE(R) (glatiramer acetate injection) along with th...m (Gd)-enhancing lesions,of the brain by 63 percen...ting multiple sclerosis (RRMS), as measured by,mag...eceiving,COPAXONE(R) alone. Additionally, the nine...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5
... package designed to assist in the operations of t...s manufacturer with years of experience in produci...cts is designed to help you run your lab the way y...,Designed specifically for integrated retail and...
The table-mounted knee retractor system provides hands-free exposure for total knee arthroplasty and revisions. The flexible, open-frame design allows for easy movement of the knee during the procedu
...urgery need. No matter the size of the incision or...tor Systems give you the best possible exposure in...mall frame arms, along with the hinged extension a...nd completely scalable access and excellent exposu...
Don't miss the sounds you need to hear! Amplify heart, lung, and other body sounds while reducing distracting ambient noise with the Littmann Model 3000., ,With Ambient Noise Reduction (ANR) tech
Medicine Products: